ACTRN12618001780246
已完成
未知
Clinical assessment of Gallus noninvasive ventilation (NIV) mask on patients in intensive care prescribed NIV.
Fisher and Paykel Healthcare0 个研究点目标入组 67 人2018年10月30日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Fisher and Paykel Healthcare
- 入组人数
- 67
- 状态
- 已完成
- 最后更新
- 4年前
概览
简要总结
The study demonstrated that the medical device was effective at delivering NIV therapy. Compared to the usual mask the study mask was found to be the same or better than the usual care mask in over 80% of cases.
研究者
入排标准
入选标准
- •All patients admitted to the Critical Care Department of Waikato Hospital that require NIV will be screened for eligibility for the study. Study participants must be adult (18 years or older and weigh more than 30kg) and require NIV in the hospital setting.
排除标准
- •Patients that fall outside of the recommended sizing range for the Gallus mask will be excluded.
- •Palliative care patients near the end of life may be omitted from the study if it is considered to be inappropriate to include them.
- •Patients can be excluded at the caregiver's discretion, for example, patients with psychological issues or agitated patients.
结局指标
主要结局
未指定